These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1829136)

  • 21. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary mucopolysaccharidoses].
    Spranger J
    Med Klin; 1971 Aug; 66(23):1105-12. PubMed ID: 4254502
    [No Abstract]   [Full Text] [Related]  

  • 23. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Musculoskeletal complications encountered in the lysosomal storage disorders.
    Pastores GM
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):937-47. PubMed ID: 19028373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression-targeted isoflavone therapy.
    Węgrzyn A
    IUBMB Life; 2012 Apr; 64(4):307-15. PubMed ID: 22362546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mucopolysaccharidoses].
    Fukuda S; Sukegawa K; Tomatsu S; Orii T
    Nihon Rinsho; 1995 Dec; 53(12):3019-24. PubMed ID: 8577052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Musculoskeletal manifestations of lysosomal storage disorders.
    Aldenhoven M; Sakkers RJ; Boelens J; de Koning TJ; Wulffraat NM
    Ann Rheum Dis; 2009 Nov; 68(11):1659-65. PubMed ID: 19822711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electron microscopy of intestinal suction-biopsy specimens as an aid in the diagnosis of mucopolysaccharidoses and other lysosomal storage diseases.
    Van Gemund JJ; Daems WT; Vio PA; Giesberts MA
    Maandschr Kindergeneeskd; 1971 Oct; 39(7):211-7. PubMed ID: 4258610
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mucopolysaccharidoses--current aspects of diagnosis and therapy].
    Fang-Kircher S
    Wien Klin Wochenschr; 1995; 107(22):698-701. PubMed ID: 8533432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic trials in mucopolysaccharidosis].
    Di Ferrante N
    Minerva Pediatr; 1975 Mar; 27(8):462-70. PubMed ID: 123308
    [No Abstract]   [Full Text] [Related]  

  • 31. Syndrome of the defective lysosome--the genetic mucopolysaccharidoses.
    Rennert OM
    Ann Clin Lab Sci; 1975; 5(5):355-62. PubMed ID: 810065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
    Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses: an evaluation.
    Gray G; Claridge P; Jenkinson L; Green A
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):360-3. PubMed ID: 17594782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early presentation in the mucopolysaccharide disorders.
    Colville GA; Bax MA
    Child Care Health Dev; 1996 Jan; 22(1):31-6. PubMed ID: 8640962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mucopolysaccharidosis: A review].
    Michaud M; Belmatoug N; Catros F; Ancellin S; Touati G; Levade T; Gaches F
    Rev Med Interne; 2020 Mar; 41(3):180-188. PubMed ID: 31959364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary excretion of mucopolysaccharides in pediatric and adolescent patients].
    de la Cruz Amorós V; Cortés Castell E; Moya M
    An Esp Pediatr; 1999 Apr; 50(4):361-6. PubMed ID: 10356828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
    Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
    Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
    Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
    Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heritable disorders of mucopolysaccharide metabolism.
    Williams HE
    Calif Med; 1967 Apr; 106(4):306-11. PubMed ID: 4227712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.